CJC-1295 (No DAC) + Ipamorelin 10mg – Research Peptide

CJC-1295 (No DAC) combined with Ipamorelin is supplied for laboratory and scientific research purposes.

Axis Therapies provides high purity research peptides manufactured in Australia, produced in controlled laboratory settings in Sydney with a focus on consistency and batch traceability.

This non-DAC formulation is commonly studied in research relating to growth hormone signalling pathways, endocrine interactions, and peptide synergy. The combination of CJC- 1295 (No DAC) and Ipamorelin is frequently used in laboratory models exploring peptide interaction and regulated biological processes.

The non-DAC format allows for investigation of shorter acting peptide behaviour without albumin binding modification, making it suitable for controlled experimental studies.

Each vial is produced to high purity standards, with batch referenced testing available where applicable.

Purity: ≥99%
Form: Lyophilised powder
Strength: 10mg per vial
Quantity: Sold per vial (multi packs available)
Manufactured in Australia (Sydney)
Testing: COA available for selected batches
This product is supplied strictly for laboratory research use only. Not for human or veterinary use.